Dr. Toni Choueiri of the Dana Farber Cancer Institute discusses CheckMate 025 phase III trial: Outcomes by key baseline factors…
Browsing: Acute Lymphoblastic Leukemia
Watch patient advocate Carol Preston, on location at the 2015 American Society of Hematology (ASH) conference, discusses the new molecule,…
As part of our coverage of the 2015 American Society of Hematology (ASH) annual meeting, MPN expert Dr. Naveen Pemmaraju…
Lymphoma expert Dr. Jeff Sharman, on location at 2015 American Society of Hematology (ASH) meeting, reviews the advancement of follicular…
At the 2015 American Society of Hematology (ASH) conference, patient advocate Carol Preston and Dr. Christopher Yasenchak, from US Oncology…
Endocrine therapy may cause many bothersome side effects, often affecting a patients compliance. Dr Naughton suggests BCI as a tool…
Is there current research for the 20 percent of CML (Chronic Myelogenous Leukemia) patients who are resistant to imatinib mesylate…
Patient Power founder caught up with leading CLL expert Dr. Thomas Kipps at the 2015 American Society of Hematology (ASH)…
Are clinical trials still a good idea for patients? Is there still a place for chemo? Who should get genetic…
At the 2015 American Society of Hematology (ASH) annual meeting, myeloma expert Dr. James Berenson joined Patient Power to discuss…
What is the REVEAL study, and why is it so important to polycythemia vera (PV) patients? On location at the…
CLL expert Dr. Jeff Sharman, on location at the ASH (American Society of Hematology) 2015 meeting, Dr. Jeff Sharman, shares…
As part of Patient Power coverage from the 2015 American Society of Hematology (ASH), myeloma experts Dr. Noopur Raje, Dr.…
As part of our coverage of the 2015 American Society of Hematology annual meeting, MPN expert Dr. Richard Silver joined…
Dr. Zeev Estrov, of MD Anderson Cancer Center, discusses fatigue in CLL patients including findings from ongoing research on JAK2…
Breast Cancer Index (BCI) validation studies included both women treated with aromatase inhibitors (AI) and women treated with tamoxifen (Tam).…
As part of our coverage of the 2015 American Society of Hematology annual meeting, myeloma expert Dr. Paul Richardson joined…
Patient Power founder Andrew Schorr led an expert panel as they reviewed CLL news from the 2015 American Society of…
As part of our coverage from the 2015 American Society of Hematology (ASH), a panel of MPN experts including Dr.…
On location in Orlando, Florida at the 2015 American Society of Hematology (ASH) annual meeting, MPN expert Dr. Naval Daver…
At the European Cancer Congress (ECC) 2015, Thomas Powles, MBBS, MRCP, MD, of Barts and The London School of Medicine…
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rachael Crayton, Oncology Specialist Nurse from Central Manchester NHS…
Patient Power founder Andrew Schorr talks with MPN expert Dr. Srdan Verstovsek to reflect on the final days of the…
Watch coverage from the 2015 American Society of Hematology (ASH) meeting with myeloma expert Dr. Robert Orlowski from MD Anderson…
Renowned CLL expert Dr. Jeff Sharman answered your questions LIVE, as we broadcasted from the 2015 American Society of Hematology…
From ASH 2015, patient advocates Andrew Schorr and Carol Preston are joined by myeloma specialist Dr. Gareth Morgan as they…
Patient advocates and hosts Andrew Schorr and Carol Preston review the highlights from the first few days of the 2015…
At the American Society of Hematology (ASH) meeting in Orlando, CLL expert Dr. Jan Burger discussed the result from the…
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute,…
The IMWG Conference Series “Making Sense of Treatment” 57th ASH Annual Meeting | Dec. 7, 2015 Drs. Brian GM Durie,…
In the era of molecular medicine, there is now a tool called Breast Cancer Index (BCI) to help physicians determine…
The IMWG Conference Series “Making Sense of Treatment” 57th ASH Annual Meeting | Dec. 7, 2015 Drs. Brian GM Durie,…
The IMWG Conference Series “Making Sense of Treatment” 57th ASH Annual Meeting | Dec. 7, 2015 Drs. Brian GM Durie,…
The IMWG Conference Series “Making Sense of Treatment” 57th ASH Annual Meeting | Dec. 7, 2015 Drs. Brian GM Durie,…
Saad Usmani, MD Levine Cancer Institute Charlotte, NC discusses the Dana Farber IFM 2009 Phase III Study of the Intergroupe…
Brian T. Hill , MD, PhD Assistant Professor, Medicine, Case Western Reserve University School of Medicine (Cleveland Clinic) discusses how…
Brian T. Hill , MD, PhD Assistant Professor, Medicine, Case Western Reserve University School of Medicine (Cleveland Clinic) discusses the…
Navneet Majhail, MD Director of the Blood and Marrow Transplant Program Cleveland Clinic discusses the fact that Precision Medicine Coming…
Navneet Majhail, MD Director of the Blood and Marrow Transplant Program Cleveland Clinic discusses Pre Transplant Depression Linked to Lower…
Navneet Majhail, MD Director of the Blood and Marrow Transplant Program Cleveland Clinic discusses a Phase 3 Randomized Trial Support…
Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic discusses how Ixazomib Has Not Shown…
Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic talks about how Elotuzumab Shows Benefits…
Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic discusses how Daratumumab will Play Increasingly…
Frederic Reu, MD Taussig Cancer Institute, Department of Hematology & Medical Oncology Cleveland Clinic talks about new ASH 2015 Data…
Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer…
Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer…
Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer…
Nitin Jain, M.D. @CLLdoc Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer…
Chemotherapy-induced nausea and vomiting (CINV) remains a concern for many cancer patients. At the United Kingdom Oncology Nursing Society (UKONS)…
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ruth Hammond, Vascular Access and IV Nurse Practitioner, and…